The ART Cohort Collaboration, which includes 21 cohort studies from Europe and North America, was established to estimate prognosis of people with HIV on highly active antiretroviral therapy (ART).

The first paper resulting from the collaboration was published in The Lancet on 13 July 2002. The database now includes information on over 200,000 patients and we regularly publish papers and contribute to major HIV conferences.

Our current research interests include:

• The impact of alcohol and substance use on prognosis
• Cause-specific mortality following the start of ART
• Estimating life expectancy following the start of ART
• Rates and causes of hospitalizations following the start of ART

All projects are initially written up as a concept sheet and discussed by the ART-CC Steering Committee. Here is a blank concept sheet (Office document, 42kB).